Mereo BioPharma Group plc

Mereo BioPharma Group plc financial statements

Mereo BioPharma Group plc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 500K10-K
Net income−USD 41.88M10-K
Cash and equivalentsUSD 40.99M10-Q
Total debtUSD 202KEODHD

Mereo BioPharma Group plc financials on 6ix · Mereo BioPharma Group plc on 6ix